A new study reveals that the presence of certain bacteria in the gut may play a significant role in influencing an individual’s response to a widely used class of antidepressants. Researchers found that these microbial communities could affect how effectively the medication is metabolized, potentially explaining why some patients experience varying levels of relief. The findings suggest that gut health might be a key factor in personalized treatment approaches for depression. The study highlights the growing intersection between microbiology and mental health research.